Paris, France

Franck Slowinski

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Genzyme Corporation, Sionna Therapeutics Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Franck Slowinski. Retrieved from https://idiyas.com/inventor/franck-slowinski-n35jsqly

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 28.0


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Franck Slowinski: Innovator in Pharmaceutical Science

Introduction

Franck Slowinski is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical science, particularly in the development of macrocyclic compounds.

Latest Patents

Slowinski holds a patent for "Macrocyclic compounds, compositions, and methods of using thereof." This patent includes CFTR modulators, pharmaceutical compositions, and methods of making and using these compounds. His innovative work in this area has the potential to impact various therapeutic applications.

Career Highlights

Throughout his career, Franck Slowinski has worked with prominent companies in the pharmaceutical industry. He has been associated with Genzyme Corporation and Sionna Therapeutics Inc., where he has contributed to advancing medical science through his research and inventions.

Collaborations

One of his notable collaborators is John E. Macor, with whom he has worked on various projects in the pharmaceutical domain.

Conclusion

Franck Slowinski's contributions to the field of pharmaceutical science, particularly through his patent and collaborations, highlight his role as an innovator. His work continues to influence the development of new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…